Document Detail


Cerebral blood flow measurement by PET in hypertensive subjects as a marker of cognitive decline.
MedLine Citation:
PMID:  20182039     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Recent epidemiological studies have shown that hypertension is a significant risk factor for Alzheimer's disease (AD). Cerebral small vessel disease (CSVD) including silent cerebral infarction and white matter lesions could represent hypertensive target organ damage in the brain and may be reliable predictors for incident dementia. However, there have been few measures to classify those patients with CSVD who are at high risk for cognitive decline and dementia. Although cerebral hypoperfusion is central to the vascular hypothesis of AD, there have been no studies linking cerebral blood flow (CBF) and future cognitive decline. Using positron emission tomography, we have demonstrated a moderate association between CBF under baseline conditions and cognitive decline during a 3-year follow-up study in 27 hypertensive patients (r=0.59, P=0.001). Findings from randomized clinical trials together with our results suggest that the preservation or improvement of CBF by anti-hypertensive treatment might be effective for the prevention of cognitive decline and dementia, especially in hypertensive patients with CSVD.
Authors:
Kazuo Kitagawa
Related Documents :
3879209 - Cerebral blood flow and brain atrophy correlated by xenon contrast ct scanning.
394669 - Failure of electroencephalography to diagnose brain death in comatose children.
6847419 - Cerebral vasomotor responsiveness during 100% oxygen inhalation in cerebral ischemia.
3872759 - Cerebral atrophy in patients on long-term regular hemodialysis treatment.
8219009 - Localization and lateralization of stereoscopic processing in the human brain.
16617999 - Encephalomalacia with enterococcus durans infection in the brain stem and cerebral hemi...
2733599 - Flow behavior of neonatal and adult erythrocytes in narrow capillaries.
17828699 - Surveillance of occupational blood and body fluid exposures among french healthcare wor...
317639 - T and b lymphocytes in patients with steroid-dependent bronchial asthma during long-ter...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Journal of Alzheimer's disease : JAD     Volume:  20     ISSN:  1875-8908     ISO Abbreviation:  J. Alzheimers Dis.     Publication Date:  2010  
Date Detail:
Created Date:  2010-06-10     Completed Date:  2010-09-08     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9814863     Medline TA:  J Alzheimers Dis     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  855-9     Citation Subset:  IM    
Affiliation:
Department of Neurology, Osaka University Graduate School of Medicine, Suita, Japan. kitagawa@medone.med.osaka-u.ac.jp
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Biological Markers / metabolism
Cerebrovascular Circulation / physiology*
Cognition Disorders / etiology,  radionuclide imaging*
Humans
Hypertension / complications,  metabolism*,  radionuclide imaging*
Positron-Emission Tomography / methods*
Chemical
Reg. No./Substance:
0/Biological Markers

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Caffeine, Diabetes, Cognition, and Dementia.
Next Document:  Caffeine and Cognition in Functional Magnetic Resonance Imaging.